Molecular modeling, synthesis, antibacterial and cytotoxicity evaluation of sulfonamide derivatives of benzimidazole, indazole, benzothiazole and thiazole. 2018

Farha Naaz, and Ritika Srivastava, and Anuradha Singh, and Nidhi Singh, and Rajesh Verma, and Vishal K Singh, and Ramendra K Singh
Bioorganic Research Laboratory, Department of Chemistry, University of Allahabad, Allahabad 211002, India.

A new series of heterocyclic molecules bearing sulfonamide linkage has been synthesized and screened for antibacterial activity. During antibacterial screening using broath dilution method, molecules were found to be highly active (MIC value 50-3.1 µg/mL) against different human pathogens, namely B. cerus, S. aureus, E. coli and P. aeruginosa, and most effective against E. coli. A great synergistic effect was observed during determination of FIC where molecules were used in combination with reference drugs chloramphenicol and sulfamethoxazole. The MIC value of the combination - varying concentration of test compounds and ½ MIC of reference drugs or varying concentration of reference drugs and ½ MIC of test compounds, was reduced up to 1/4 or 1/32 of the original value, indicating thereby the combination was 4-32 times more potent than the test molecule. The molecules also showed low degree of cytotoxicity against PBM, CEM and VERO cell lines. The results positively indicated towards the development of lead antibacterials using the combination approach.

UI MeSH Term Description Entries
D007191 Indazoles A group of heterocyclic aromatic organic compounds consisting of the fusion of BENZENE and PYRAZOLES. Indazole
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D001562 Benzimidazoles Compounds with a BENZENE fused to IMIDAZOLES.

Related Publications

Farha Naaz, and Ritika Srivastava, and Anuradha Singh, and Nidhi Singh, and Rajesh Verma, and Vishal K Singh, and Ramendra K Singh
November 2017, Molecules (Basel, Switzerland),
Farha Naaz, and Ritika Srivastava, and Anuradha Singh, and Nidhi Singh, and Rajesh Verma, and Vishal K Singh, and Ramendra K Singh
February 2021, Bioorganic chemistry,
Farha Naaz, and Ritika Srivastava, and Anuradha Singh, and Nidhi Singh, and Rajesh Verma, and Vishal K Singh, and Ramendra K Singh
June 2015, European journal of medicinal chemistry,
Farha Naaz, and Ritika Srivastava, and Anuradha Singh, and Nidhi Singh, and Rajesh Verma, and Vishal K Singh, and Ramendra K Singh
July 2023, Molecular diversity,
Farha Naaz, and Ritika Srivastava, and Anuradha Singh, and Nidhi Singh, and Rajesh Verma, and Vishal K Singh, and Ramendra K Singh
April 2015, Marine drugs,
Farha Naaz, and Ritika Srivastava, and Anuradha Singh, and Nidhi Singh, and Rajesh Verma, and Vishal K Singh, and Ramendra K Singh
February 2003, Bioorganic & medicinal chemistry letters,
Farha Naaz, and Ritika Srivastava, and Anuradha Singh, and Nidhi Singh, and Rajesh Verma, and Vishal K Singh, and Ramendra K Singh
January 2023, Molecules (Basel, Switzerland),
Farha Naaz, and Ritika Srivastava, and Anuradha Singh, and Nidhi Singh, and Rajesh Verma, and Vishal K Singh, and Ramendra K Singh
January 2013, Biocontrol science,
Farha Naaz, and Ritika Srivastava, and Anuradha Singh, and Nidhi Singh, and Rajesh Verma, and Vishal K Singh, and Ramendra K Singh
January 2021, Drug design, development and therapy,
Farha Naaz, and Ritika Srivastava, and Anuradha Singh, and Nidhi Singh, and Rajesh Verma, and Vishal K Singh, and Ramendra K Singh
December 1995, Arzneimittel-Forschung,
Copied contents to your clipboard!